Spectrum Fertility Group is pleased to announce that our Chief Executive Officer, Angela Prothmann, attended the 2024 Preimplantation Genetic Diagnosis International Society (PGDIS) Conference in Kuala Lumpur, Malaysia. She was accompanied by representatives from our strategic partner, NVWA Life Technology, a leader in cutting-edge epigenetic reproductive health technologies.

The PGDIS Conference took place from May 5-8, 2024 and is a premier global event that brings together leading scientists, clinicians, and industry professionals in the field of reproductive genetics. The conference serves as a platform for sharing the latest research, advancements, and technologies in preimplantation genetic diagnosis (PGD) and related fields.

Dr. Liu Jiang, Chief Science Officer, presented NVWA’s latest innovations in embryo screening and fertility treatment optimization called Pre-implantation DNA Methylation Screening (PIMS). His presentation, titled "Advancements in Non-Invasive Preimplantation Genetic Testing," highlighted the company's pioneering epigenetic research and its potential to improve IVF success rates while minimizing risks to both patients and embryos.

"We are excited to showcase our latest research at the PGDIS Conference," said Dr. Liu. "We are committed to developing advanced genetic testing solutions that are both accurate and non-invasive. This partnership allows us to combine our expertise and deliver better outcomes for patients around the world."

NVWA Life Technology's CSO, Dr. Liu Jiang, will also be in attendance, underscoring the strong partnership between the two companies. Dr. Liu commented, "Joining forces with Spectrum Fertility Group enables us to leverage our collective knowledge and resources to push the boundaries of what’s possible in reproductive health. We look forward to engaging with the global community after the PGDIS conference and exploring new opportunities for collaboration."

The Spectrum Fertility Group and NVWA Life Technology team are available for meetings and discussions post conference. Conference attendees are encouraged to visit our website for more information on products and services, and to learn more about latest research findings.

For more information about Spectrum Fertility Group, please contact:

Media Contact:

Director of Communications
Spectrum Fertility Group Inc.
Email: info@spectrumfertility.com

About Spectrum Fertility Group: Spectrum Fertility Group is a leading provider of innovative fertility solutions, committed to helping individuals and couples achieve their dream of parenthood. With a focus on advanced genetic testing and personalized treatment plans, Spectrum Fertility Group offers cutting-edge services to improve IVF outcomes and reproductive health.

About NVWA Life Technology: NVWA Life Technology specializes in the development of advanced epigenetic reproductive health technologies. With a mission to improve patient care through innovation, NVWA Life Technology provides state-of-the-art solutions for genetic testing and fertility treatments, supporting clinicians and patients worldwide.